Anti-glaucoma composition and method

Details Anti-glaucoma composition and method Anti-glaucoma composition and method

1977-01-27

1978-11-21

Meyers, Albert T.

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

Lipid or oil

A61K 3135

Patent

active

041266951

ABSTRACT:
Tetrahydrodibenzopyrans having the structure ##STR1## in which R.sub.1 is hydrogen or acetyl and R.sub.2 is alkyl having from 1 to 4 carbon atoms are effective anti-glaucoma agents, free from all but a very small amount of CNS activity, when applied topically.

REFERENCES:
patent: 3668224 (1972-06-01), Petrzilka
patent: 3728360 (1974-04-01), Pars et al.
patent: 3734930 (1973-05-01), Razdan et al.
patent: 3799946 (1974-03-01), Loev
patent: 3920809 (1975-11-01), Thakkar
patent: 4025536 (1977-05-01), Korte et al.
Ophthalmologica 168:366-369 (1974)-D. Shapiro The Ocular Manifestations of the Cannabinols Newsweek, Nov. 8, 1976 -Pot and Glaucoma.
Chem. Abst. 83 158,044(r) (1975)-Purnell et al. ".DELTA..sup.9 -Tetrahydrocannabinol-in Man."
Chem. Abst. 84 130270(h) (1976) Green et al.-Interaction of--Tetrahydrocannabinol in the Eye."

Affiliated with

Also associated with

Rating

Anti-glaucoma composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-glaucoma composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-glaucoma composition and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2049710